People | January 23, 2023
SK bioscience appoints new executives
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
The company will not receive any proceeds from the offer as all of it will go to the promoter selling shareholder.
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
Moderna and Merck announced mRNA-4157/V940, in combination with KEYTRUDA, demonstrated a 44% reduction in the risk of disease recurrence or death in melanoma patients
Chyawanprash Special will be available at all Jan Aushadhi Kendras
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
Honan will lead the company in identifying and executing acquisitions that complement Emmes’ existing strong federal government client base, expand its biopharma portfolio, enhance its technology offerings, and broaden its global reach
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Subscribe To Our Newsletter & Stay Updated
